knowledge
Previous article:
How to save PrEP access — and even expand it
Next article: ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug
Next article: ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug
focus
knowledge
-
GSK’s asthma push continues as drug succeeds in Phase 3 trials
2025-09-30 22:59 -
The creative science of coining drug names
2025-09-30 22:22 -
The effects of a landmark ruling on DNA ownership are becoming clearer
2025-09-30 22:11 -
ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug
2025-09-30 21:40 -
ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?
2025-09-30 21:27 -
Welsh Carson private equity firm escapes from FTC antitrust case
2025-09-30 21:05